Target controlled infusion

Target-controlled infusion (TCI) automates the dosing of intravenous drugs during surgery. After the anesthetist sets the desired parameters in a computer and presses the start button, the system controls the infusion pump, while being monitored by the anesthetist.[1] TCI is as safe and effective as manually controlled infusion.[2][3]

TCI can be sub-classified according to the target. The suffix 'e' as in TCIe indicates that the target is the effect site, in most cases, the central nervous system or brain. Alternatively, the suffix 'p' denotes plasma, indicating that the device implementing the TCI model is to target the blood plasma. There are important differences in relation to the time taken for effect site equilibration. Studies have demonstrated the clinical safety of the effect-site target model.[4]

Popular TCI models exist for Propofol and the synthetic opioid Remifentanil. The models are based on pharmacokinetic studies and use software embedded in the infusion device. For propofol the Marsh and Schnider models are available and the Minto model is commonly used for remifentanil. In 2017, a project to emulate the TCI models in the python language was published on GitHub.


History

TCI has been used in clinical settings since 1996, initially with propofol.[5]

See also

References

  1. Absalom, Anthony R.; Glen, John (Iain) B.; Zwart, Gerrit J. C.; Schnider, Thomas W.; Struys, Michel M. R. F. (2016). "Target-Controlled Infusion". Anesthesia & Analgesia. 122 (1): 70–78. doi:10.1213/ANE.0000000000001009. ISSN 0003-2999. PMID 26516798. S2CID 41023659.
  2. Hunt-Smith J, Donaghy A, Leslie K, Kluger M, Gunn K, Warwick N (June 1999). "Safety and efficacy of target controlled infusion (Diprifusor) vs manually controlled infusion of propofol for anaesthesia". Anaesth Intensive Care. 27 (3): 260–4. doi:10.1177/0310057x9902700306. PMID 10389558. Retrieved 2018-06-28.
  3. Schraag, Stefan (2001). "Theoretical basis of target controlled anaesthesia: history, concept and clinical perspectives". Best Practice & Research Clinical Anaesthesiology. 15 (1): 1–17. doi:10.1053/bean.2001.0132. ISSN 1521-6896.
  4. Struys, M. M.; De Smet, T.; Depoorter, B.; Versichelen, L. F.; Mortier, E. P.; Dumortier, F. J.; Shafer, S. L.; Rolly, G. (February 2000). "Comparison of plasma compartment versus two methods for effect compartment--controlled target-controlled infusion for propofol". Anesthesiology. 92 (2): 399–406. doi:10.1097/00000542-200002000-00021. PMID 10691226. S2CID 36108017.
  5. Struys MM, De Smet T, Glen JI, Vereecke HE, Absalom AR, Schnider TW (January 2016). "The History of Target-Controlled Infusion". Anesth. Analg. 122 (1): 56–69. doi:10.1213/ANE.0000000000001008. PMID 26516804. S2CID 39391491. Retrieved 2018-06-29.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.